SS

Swetaben Shambhudan Gadhavi

Active Director Designated Partner DIN 10462887
DIN 10462887 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Swetaben Shambhudan Gadhavi

Data last updated:

Swetaben Shambhudan Gadhavi is a Designated Partner at Sai Re-Cos Pharma Llp (since 2024).

DIN 10462887
Primary Designation Designated Partner
First Appointment 12 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Jan 20242024Active

Board colleagues of Swetaben Shambhudan Gadhavi

NameDINCompanyDesignation
Ganesh Laxman Kanojiya10462886Sai Re-Cos Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sai Re-Cos Pharma Llp
Premium access

Shareholding and investment profile for Swetaben Shambhudan Gadhavi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swetaben Shambhudan Gadhavi

Swetaben Shambhudan Gadhavi currently holds 1 directorship: Sai Re-Cos Pharma Llp (Designated Partner, since 12 Jan 2024).

Swetaben Shambhudan Gadhavi was first appointed on 12 Jan 2024 as Designated Partner at Sai Re-Cos Pharma Llp.

The current boards of Swetaben Shambhudan Gadhavi's companies include Ganesh Laxman Kanojiya (Sai Re-Cos Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available